GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: CGP 19835 | CGP-19835 | L-MTP-PE | liposomal muramyl tripeptide phosphatidyl ethanolamine | Mepact® | MLV 19835A
                                 mifamurtide is an approved drug (EMA (2009)) Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: Mifamurtide is a synthetic analogue of the bacterial cell wall component, muramyl dipeptide (MDP). MDP stimulates the immune system via activation of microbial pattern recognition receptors such as TLR4 and NOD2 [3,9].
                                    
                                   View more information in the IUPHAR Pharmacology Education Project: mifamurtide | 
 | |||||||||||||||||||||||||||||||||||
| Classification  | |
| Compound class | Synthetic organic | 
| Approved drug? | Yes. EU EMA (2009) | 
| International Nonproprietary Names  | |
| INN number | INN | 
| 8744 | mifamurtide | 
| Synonyms  | 
| CGP 19835 | CGP-19835 | L-MTP-PE | liposomal muramyl tripeptide phosphatidyl ethanolamine | Mepact® | MLV 19835A | 
| Database Links  | |
| CAS Registry No. | 83461-56-7 | 
| GtoPdb PubChem SID | 252166486 | 
| PubChem CID | 23725094 | 
| Search Google for chemical match using the InChIKey | JMUHBNWAORSSBD-ZXSMYVEWSA-N | 
| Search Google for chemicals with the same backbone | JMUHBNWAORSSBD | 
| Search PubMed clinical trials | mifamurtide | 
| Search PubMed titles | mifamurtide | 
| Search PubMed titles/abstracts | mifamurtide | 
| UniChem Compound Search for chemical match using the InChIKey | JMUHBNWAORSSBD-ZXSMYVEWSA-N | 
| UniChem Connectivity Search for chemical match using the InChIKey | JMUHBNWAORSSBD-ZXSMYVEWSA-N |